Finance

Lists
6OD:FRA
Odi Pharma AB (publ)
€0.17
0.00%
(0.00) 1D
Sep 10, 8:07:14 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6OD...
Open
€0.17
High
€0.17
Low
€0.17
Volume
0.00
52-wk high
€0.40
52-wk low
€0.06
No. of employees
1
Open
€0.17
High
€0.17
Low
€0.17
Volume
0.00
52-wk high
€0.40
52-wk low
€0.06
No. of employees
1
About Odi Pharma AB (publ)
CEO-
Employees1
Founded2018
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.97M
10.93M
12.71M
3.20M
Cost of goods sold
4.47M
7.30M
9.27M
1.51M
Cost of revenue
4.47M
7.30M
9.27M
1.51M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.24M
2.20M
2.81M
1.41M
Operating expense
1.39M
2.14M
3.13M
1.53M
Total operating expenses
5.86M
9.45M
12.40M
3.05M
Operating income
111.92K
1.49M
309.94K
149.23K
Other non operating income
-
-
-
-
EBT including unusual items
-37.03K
1.30M
126.61K
153.04K
EBT excluding unusual items
-37.03K
1.30M
126.61K
153.04K
Income tax expense
24.00
-
-
-
Effective tax rate
-0.06%
-
-
-
Other operating expenses
141.06K
-55.85K
315.85K
119.24K
Net income
-37.05K
1.30M
126.61K
153.04K
Net profit margin
-0.62%
11.88%
1.00%
4.79%
Earnings per share
-
-
-
-
Interest and investment income
3.09K
10.15K
1.00
72.69K
Interest expense
-152.03K
-196.61K
-183.32K
-68.88K
Net interest expenses
-148.94K
-186.46K
-183.32K
3.81K
Depreciation and amortization charges
342.00
1.43K
1.42K
1.45K
EBITDA
112.26K
1.49M
311.36K
150.68K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps